1. Risk of using hydroxychloroquine as a treatment of COVID-19;Alanagreh;Int. J. Risk Saf. Med.,2020
2. Adverse effects and drug interactions of clinical importance with antiviral drugs;Morris;Drug Saf.,1994
3. Stefano Norbedo, Susanna Bosi, Massimo Bergamin, Riaz Ahmed Khan, Erminio Murano, Use of hyaluronic acid as a carrier molecule for different classes of therapeutic active agents , WO/2007/085629, EP1976539, US20090197797, CN101374531, CA2640159, AU2007209366, JP2009524624, IN4408/CHENP/2008
4. Chemistry of hyaluronic acid and its significance in drug delivery strategies: a review;Khan;Int. J. Pharm. Sci. Res.,2013
5. Hyaluronic acid - hydroxychloroquine conjugate proposed for treatment of COVID-19;Khan;Int. J. Adv. Sci. Eng.,2020